Novavax Inc. (NVAX)

$ 8.70
   
  • Change Today:
    $0.45
  • 52 Week High: $10.33
  • 52 Week Low: $5.39
  • Currency: US Dollars
  • Shares Issued: 23.47m
  • Volume: 3,999,408
  • Market Cap: $204.22m
  • RiskGrade: 720

Deal with Barclays    Trade now with Barclays Stockbrokers

Novavax Inc. Overview

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Novavax Inc. Fundamentals

Fundamentals data is not available for this company.

Novavax Inc. Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-26 381.22 (61.79) (30.97)¢ n/a n/a n/a n/a 0.0%
31-Dec-27 269.20 (25.44) 9.45¢ 92.1 n/a n/a n/a 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Novavax Inc. ShareCast News

US close: Stocks slide on automotive tariff conc... 27-Mar-2025 ShareCast
Novavax signs $1.2bn Covid-19 licensing deal wit... 10-May-2024 ShareCast
Novavax to cut global workforce by a quarter 09-May-2023 ShareCast

Novavax Inc. Top Newspaper Links

Local Digest 10-May-2009 Washington Post
Novavax Moves Closer to Licensing Bird Flu Vaccine 27-Aug-2008 Washington Post
Business Briefing 09-Aug-2008 Washington Post

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

Novavax Inc. Market Data

Currency US Dollars
Share Price $ 8.70
Change Today $ 0.45
% Change 5.45 %
52 Week High $10.33
52 Week Low $5.39
Volume 3,999,408
Shares Issued 23.47m
Market Cap $204.22m
RiskGrade 720

What The Brokers Say

Strong Buy 2
Buy 3
Neutral 1
Sell 2
Strong Sell 1
Total 9
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 09-Feb-2026

Time Volume / Share Price
15:59 200 @ $8.69
15:59 140 @ $8.70
15:59 100 @ $8.70
15:59 100 @ $8.69
15:59 100 @ $8.70

Top of Page